Is Magno-Humphries, Inc. FDA approved?

Magno-Humphries, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Magno-Humphries, Inc.'s registered sites?

The FDA register lists Tigard, OR. Registered operations: labelling, relabelling, repackaging.

What drugs does Magno-Humphries, Inc. make?

17 products are listed under Magno-Humphries, Inc. in the openFDA NDC Directory, most often as tablet; tablet, film coated; capsule, gelatin coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Magno-Humphries, Inc.

Data as of 28 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 17
Live patents: 0
Countries: 1
Base: United States

Authorisation

Registered operations

Labelling1Relabelling1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Magno-Humphries, Inc.	8800 Southwest Commercial Street, Tigard, Oregon (OR) 97223, United States (USA)	Labelling, Relabelling, Repackaging	3021503063251433

Catalogue

Drug listings by form and route

17 active NDC listings: 17 human otc drug. By marketing category: OTC MONOGRAPH DRUG 12, ANDA 5.

Dosage form	NDCs
tablet	14
tablet, film coated	2
capsule, gelatin coated	1

Route	NDCs
oral	17

Labeller name on the listing	NDCs
magno-humphries, inc.	17

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
Acetaminophen Extended-Release	ACETAMINOPHEN	tablet, oral	54257-573ANDA
Acetaminophen Regular Strength	ACETAMINOPHEN	tablet, oral	54257-720OTC MONOGRAPH DRUG
Allergy Relief	FEXOFENADINE HYDROCHLORIDE	tablet, oral	54257-170ANDA
Allergy Relief	CETIRIZINE HYDROCHLORIDE	tablet, oral	54257-270ANDA
ENTERIC COATED ASPIRIN	ASPIRIN	tablet, oral	54257-274OTC MONOGRAPH DRUG
Extraprin	ACETAMINOPHEN, ASPIRIN, CAFFEINE	tablet, oral	54257-858OTC MONOGRAPH DRUG
FIBER LAXATIVE	CALCIUM POLYCARBOPHIL	tablet, oral	54257-479OTC MONOGRAPH DRUG
Famotidine	Famotidine	tablet, film coated, oral	54257-180ANDA
Famotidine	Famotidine	tablet, film coated, oral	54257-802ANDA
Fiber Laxative	CALCIUM POLYCARBOPHIL	tablet, oral	54257-379OTC MONOGRAPH DRUG
Mucosa DM	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	tablet, oral	54257-277OTC MONOGRAPH DRUG
Mucosa Guifenesin	GUAIFENESIN	tablet, oral	54257-776OTC MONOGRAPH DRUG
Pain Reliever	ACETAMINOPHEN	tablet, oral	54257-473OTC MONOGRAPH DRUG
Pain Reliever PM	ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE	tablet, oral	54257-278OTC MONOGRAPH DRUG
Senna S	DOCUSATE SODIUM, SENNOSIDES	tablet, oral	54257-089OTC MONOGRAPH DRUG
Sennosides Natural Laxative	SENNOSIDES	tablet, oral	54257-679OTC MONOGRAPH DRUG
Stool Softener Docusate Sodium	DOCUSATE SODIUM	capsule, gelatin coated, oral	54257-902OTC MONOGRAPH DRUG

Compare

Comparable companies in United States

Bryant Ranch Prepack1 site · 4,357 NDC
Proficient Rx LP1 site · 1,729 NDC
RemedyRepack, Inc1 site · 1,521 NDC
Preferred Pharmaceuticals Inc.1 site · 1,046 NDC
PD-Rx Pharmaceuticals Inc.1 site · 828 NDC
Camber Pharmaceuticals, Inc.1 site · 640 NDC
Northwind Health Company, LLC1 site · 580 NDC
Direct Rx1 site · 554 NDC
Professional Compounding Centers of America dba PCCA1 site · 487 NDC
Coupler LLC1 site · 469 NDC

Enquiry

Common questions

Is Magno-Humphries, Inc. FDA approved?: Magno-Humphries, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Magno-Humphries, Inc.'s registered sites?: The FDA register lists Tigard, OR. Registered operations: labelling, relabelling, repackaging.
What drugs does Magno-Humphries, Inc. make?: 17 products are listed under Magno-Humphries, Inc. in the openFDA NDC Directory, most often as tablet; tablet, film coated; capsule, gelatin coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.